<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Benzyl alcohol: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Benzyl alcohol: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Benzyl alcohol: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12187" href="/d/html/12187.html" rel="external">see "Benzyl alcohol: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="13083" href="/d/html/13083.html" rel="external">see "Benzyl alcohol: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F7897463"><span class="drugH1">Brand Names: US</span>
<ul>
<li>AverTeaX [OTC];</li>
<li>Ulesfia [DSC];</li>
<li>Zilactin [OTC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F7695207"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Analgesic, Topical;</li>
<li>
                        Antiparasitic Agent, Topical;</li>
<li>
                        Pediculocide;</li>
<li>
                        Topical Skin Product</li></ul></div>
<div class="block doa drugH1Div" id="F7897495"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Note: </b>Ulesfia lotion has been discontinued in the United States for &gt;1 year.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="25064afa-9a59-45fb-8b65-21ea8519d52d">Head lice</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Head lice:</b>
<b>Topical:</b> Lotion: Apply appropriate volume for hair length to dry hair and completely saturate the scalp; leave on for 10 minutes; rinse thoroughly with water; repeat in 7 days.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 0 to 2 inches: 4 to 6 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 2 to 4 inches: 6 to 8 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 4 to 8 inches: 8 to 12 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 8 to 16 inches: 12 to 24 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 16 to 22 inches: 24 to 32 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length &gt;22 inches: 32 to 48 ounces.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d7453afe-7743-42ed-97db-f73e94a5b8e1">Oral pain</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral pain:</b>
<b>Topical:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Gel: Apply to affected area up to 4 times daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Ointment: Apply to affected area as needed.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50989963"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987284"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F7897496"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F7897494"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="13083" href="/d/html/13083.html" rel="external">see "Benzyl alcohol: Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Ulesfia lotion has been discontinued in the United States for &gt;1 year.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="25064afa-9a59-45fb-8b65-21ea8519d52d">Head lice</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Head lice</b>: Infants ≥6 months, Children, and Adolescents: Lotion (Ulesfia): Apply appropriate volume for hair length to dry hair, saturate the scalp completely, leave on for 10 minutes, rinse thoroughly with water; repeat in 7 days.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 0 to 2 inches: 4 to 6 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 2 to 4 inches: 6 to 8 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 4 to 8 inches: 8 to 12 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 8 to 16 inches: 12 to 24 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length 16 to 22 inches: 24 to 32 ounces.</p>
<p style="text-indent:-2em;margin-left:4em;">Hair length &gt;22 inches: 32 to 48 ounces.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d7453afe-7743-42ed-97db-f73e94a5b8e1">Oral pain</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral pain: </b>Children ≥2 years and Adolescents: Topical: Gel (Zilactin): Apply to affected area up to 4 times/day; do not use for more than 7 days.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51073647"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block dohp drugH1Div" id="F51073648"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F7897483"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Dermatologic: Pruritus (12%), erythema (10%) </p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Central nervous system: Local anesthesia (2%), hypoesthesia (2%; local)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local irritation (2%), local pain (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Eye irritation (6%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%, postmarketing, and/or case reports: Dermatitis, desquamation, excoriation, paresthesia, seborrheic dermatitis of scalp, skin rash, thermal injury, xeroderma</p></div>
<div class="block coi drugH1Div" id="F7897469"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">There are no contraindications listed in the manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">OTC labeling: When used for self-medication, do not use if allergic to benzyl alcohol or any component of the formulation.</p></div>
<div class="block war drugH1Div" id="F7897470"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Contact dermatitis: Allergic or irritant dermatitis may occur.</p>
<p style="text-indent:-2em;margin-left:4em;">• Eye irritation: Avoid eye exposure. If eye is exposed, flush immediately with water.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Children: Use under direct adult supervision. Keep out of children's reach. Lotion for the treatment of head lice is not recommended for infants &lt;6 months due to the potential for increased absorption. Do not use gel for oral pain in infants or children younger than 2 years.</p>
<p style="text-indent:-2em;margin-left:4em;">• Neonates: Intravenous administration of benzyl alcohol-containing products has been associated with a neonatal gasping syndrome. Patients &lt;1 month of age or premature neonates with a corrected gestational age &lt;44 weeks could be at risk if treated with topical benzyl alcohol.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): Discontinue use and notify health care provider if condition worsens or does not improve within 7 days, or if swelling, rash, or fever develops. Do not use for &gt;7 days unless instructed by health care professional.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878724"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block prod-avail drugH1Div" id="F55806266"><span class="drugH1">Product Availability</span>
<p style="text-indent:0em;display:inline">Ulesfia lotion has been discontinued in the United States for &gt;1 year.</p></div>
<div class="block foc drugH1Div" id="F7897529"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, Mouth/Throat: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zilactin: 10% (7.1 g) [contains propylene glycol, sd alcohol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lotion, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ulesfia: 5% (227 g [DSC]) [contains polysorbate 80, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Ointment, Mouth/Throat: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">AverTeaX: 1% (7.4 mL) [contains cetyl alcohol, propylene glycol, trolamine (triethanolamine)]</p></div>
<div class="block geq drugH1Div" id="F7897643"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F16570424"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Zilactin Mouth/Throat)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10% (per gram): $0.70</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (AverTeaX Mouth/Throat)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $1.35</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F7897525"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">For topical use only.</p>
<p style="text-indent:-2em;margin-left:2em;">Gel: Dry affected area and apply only with moistened cotton swab or clean finger. Allow to dry 30 to 60 seconds. Do not peel off protective film; to remove film, first apply another coat of benzyl alcohol to film, and immediately wipe the area with a moist gauze pad or tissue.</p>
<p style="text-indent:-2em;margin-left:2em;">Lotion: Apply to dry hair until completely saturated. Leave on for 10 minutes, followed by a thorough water rinse. Avoid contact with eyes. Wash hands after application. Use in conjunction with an overall lice management program. Dry clean or wash all clothing, hats, bedding, and towels in hot water. Wash all personal care items (eg, combs, brushes, hair clips) in hot water. May use a fine-tooth or special nit comb to remove nits and dead lice.</p>
<p style="text-indent:-2em;margin-left:2em;">Ointment: For best results, apply at the first sign of symptoms (eg, itching, redness, tightness, tingling).</p></div>
<div class="block admp drugH1Div" id="F52614296"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">For external topical use only; avoid contact with eyes. Do not swallow.</p>
<p style="text-indent:-2em;margin-left:2em;">Gel: Dry affected area and apply only with moistened cotton swab or clean finger. Allow to dry 30 to 60 seconds. Do not peel off protective film; to remove film, first apply another coat of benzyl alcohol to film and immediately wipe the area with a moist gauze pad or tissue.</p>
<p style="text-indent:-2em;margin-left:2em;">Lotion: Apply under adult supervision to dry hair, until entire scalp and hair are saturated. Leave on for 10 minutes then rinse thoroughly. Wash hands after application. Use in conjunction with an overall lice management program. Dry clean or wash all clothing, hats, bedding, and towels in hot water. Wash all personal care items (eg, combs, brushes, hair clips) in hot water. A lice comb may be used to remove dead lice after both treatments.</p></div>
<div class="block use drugH1Div" id="F7695209"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Head lice</b> (lotion only): Treatment of head lice infestation in patients 6 months and older.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral pain:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Gel: Temporary relief of pain from cold sores/fever blisters, canker sores, mouth sores, and/or gum irritations in patients 2 years and older.</p>
<p style="text-indent:-2em;margin-left:4em;">Ointment: Temporary relief of pain and itching associated with fever blisters and cold sores.</p></div>
<div class="block mst drugH1Div" id="F7695205"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Benzyl alcohol may be confused with benzoyl peroxide</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13298848"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F7899266"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F7897465"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Only minimal systemic absorption is expected when benzyl alcohol is used topically as indicated (Koch 2016).</p></div>
<div class="block brc drugH1Div" id="F7897468"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is unknown if benzyl alcohol is present in breast milk.</p>
<p style="text-indent:-2em;margin-left:2em;">Only minimal systemic absorption is expected when benzyl alcohol is used topically as indicated (Koch 2016).</p></div>
<div class="block pha drugH1Div" id="F7897523"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Inhibits respiration of lice by obstructing respiratory spiracles causing lice asphyxiation. No ovicidal activity.</p></div>
<div class="block phk drugH1Div" id="F7897490"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Absorption: Lotion: Following a prolonged application (30 minutes), serum concentrations were detectable (≤3 mcg/mL) at 30 and 60 minutes postexposure in patients 6 months to 11 years of age.</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/benzyl-alcohol-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Averteax (benzyl alcohol) [prescribing information]. Augusta, GA: Carmellix, LLC; received March 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/benzyl-alcohol-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20660553">
<a name="20660553"></a>Frankowski BL and Bocchini JA Jr, “Head Lice,” <i>Pediatrics</i>, 2010, 126(2):392-403.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/benzyl-alcohol-drug-information/abstract-text/20660553/pubmed" id="20660553" target="_blank">20660553</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/benzyl-alcohol-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27595869">
<a name="27595869"></a>Koch E, Clark JM, Cohen B, et al. Management of head louse infestations in the United States—a literature review. <i>Pediatr Dermatol</i>. 2016;33(5):466‐472. doi:10.1111/pde.12982<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/benzyl-alcohol-drug-information/abstract-text/27595869/pubmed" id="27595869" target="_blank">27595869</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/benzyl-alcohol-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Ulesfia lotion (benzyl alcohol) [prescribing information]. Dublin, Ireland: Lachlan Pharmaceuticals; June 2015.</div>
</li>
<li>
<div class="reference">
                  Ulesfia (benzyl alcohol) [prescribing information]. Dublin, Ireland: Lachlan Pharmaceuticals; April 2020.</div>
</li>
<li>
<div class="reference">
                  Zilactin (benzyl alcohol gel) [prescribing information]. Columbus, IN: Blairex Laboratories Inc; August 2013.</div>
</li></ol></div><div id="topicVersionRevision">Topic 9067 Version 127.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
